Browse the full report's details here: https://proficientmarket.com/report/1468/global-smart-syringe-market
Usage of smart syringes is witnessing a huge demand for preventing the spread of diseases between patients. According to WHO, improper usage and reuse of syringes has been recorded which leads to transfer of diseases among patients, therefore, utilization of smart syringes are increasingly being used. Especially at present there is high growth of the smart syringe market due to increasing need for vaccination of patients to reduce the spread of diseases, COVID-19 is on the surge due to which there is an elevated need for smart syringes to contain the virus such that it does not spread from one individual to another and thereby at present there is a higher growth of the market. According to a report it states that about 16 billion injections are administered to individuals annually thereby the WHO states that smart syringes can aid in eliminating about 1.7 million hepatitis B cases, 300,000 hepatitis C cases and 35,000 HIV cases each year thereby WHO has made it mandatory to use smart syringes by the year 2020 such that it can eliminate re-use of syringes and aid in safe treatment of patients. Vaccinations are being given in large numbers on a daily basis for patients to fight COVID-19 and thereby smart syringes are increasingly being needed for injecting the vaccines into the body of the individuals, on an other hand there is an equal need to test individuals for COVID-19 therefore collection of blood is also carried out through smart syringes and denies the re-use for collecting other blood samples with the same syringe. Thereby, these factors are expected to increase the growth and disposable income of the market globally.
Several types such as liquid smart syringes, headspace smart syringes, among others are increasingly being used for vaccination purpose during COVID-19. Rising use of liquid smart syringes for drug delivery as well as to inject the exact amount of drug into the body is growing the sales of liquid smart syringes globally. Liquid smart syringes are being used increasingly for collection of blood samples to test COVID-19 antibodies and presence of the virus as well as for different drug administrations and for various purposes, liquid syringes are on demand as they are easy to use and can be injected into the skin directly as the amount of drug needed is only injected into the body. Thereby, such factors are enhancing the growth of the liquid smart syringe segment for the market.
Well established companies are focusing on investments in research and development sector to develop new techniques and collaborations for promoting the use of smart syringes. Thereby, the overall smart syringe market is anticipated to grow significantly in the following years due to the availability of a wide variety of product offerings and need for public health safety. The companies are also investing towards COVID-19 testing and relief thereby for these needs the companies are designing innovating products such as smart syringes to aid in cubing the spread of the virus and to carry out viral testing with ease. Some of the key players in the market include Becton, Dickinson and Company, Terumo Corporation, Braun Melsungen AG, Baxter International, Inc., Retractable Technologies, Inc., Smiths Group Plc, Unilife Corporation, Revolutions Medical Corporation, Cardinal Health, Inc. and CTC Analytics AG (PAL).
Trends and Future Outlook:
- The World Health Organization has stated that by the year 2020 the multi usage injections have to be replaced with smart syringes to reduce the spread of diseases through reused syringes.
- In August 2020, Hindustan Syringes & Medical Devices Ltd has announced that they have received an order from the (UNICEF) united nations children fund to send around 140 million auto disable syringes to handle the COVID-19 situation.